List of Minerva Neurosciences patents

List of Minerva Neurosciences patents

List of Centric Software patents

List of Spyderco patents

List of Oe Solutions patents

List of awards received by Kirsten Dunst

List of companies in Liberty Technology Venture Capital's investment portfolio

Patents where

Current Assignee

Name

is

Minerva Neurosciences

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9732059 Methods of use of cyclic amide derivatives to treat schizophrenia	Patent 9732059 was granted and assigned to Minerva Neurosciences on August, 2017 by the United States Patent and Trademark Office.		Minerva Neurosciences		United States Patent and Trademark Office	9732059	August 15, 2017
	‌ US Patent 10258614 Compositions and methods for treating schizophrenia	Patent 10258614 was granted and assigned to Minerva Neurosciences on April, 2019 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	10258614	April 16, 2019
	‌ US Patent 9730920 Compositions and methods for treating schizophrenia	Patent 9730920 was granted and assigned to Minerva Neurosciences on August, 2017 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	9730920	August 15, 2017
	‌ US Patent 11083723 Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection	Patent 11083723 was granted and assigned to Minerva Neurosciences on August, 2021 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	11083723	August 10, 2021
	‌ US Patent 9458130 Compositions and methods for treating schizophrenia	Patent 9458130 was granted and assigned to Minerva Neurosciences on October, 2016 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	9458130	October 4, 2016
	‌ US Patent 11464744 Gastro-resistant controlled release oral dosage forms	Patent 11464744 was granted and assigned to Minerva Neurosciences on October, 2022 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	11464744	October 11, 2022
	‌ US Patent 10799493 Compositions and methods for treating schizophrenia	Patent 10799493 was granted and assigned to Minerva Neurosciences on October, 2020 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	10799493	October 13, 2020
	‌ US Patent 11766430 Methods of using a phenoxypropylamine compound to treat pain	Patent 11766430 was granted and assigned to Minerva Neurosciences on September, 2023 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	11766430	September 26, 2023
	‌ US Patent 12006300 Sigma ligand compounds and uses thereof	Patent 12006300 was granted and assigned to Minerva Neurosciences on June, 2024 by the United States Patent and Trademark Office.	Minerva Neurosciences	Minerva Neurosciences		United States Patent and Trademark Office	12006300	June 11, 2024

9 results

0 selected

9 results

0 selected